European Commission answers tabled questions on heart failure in EU health programmes

News & Events

22 April 2024
AUTHOR: Jonathan Cooke

In early 2024, two Policy Champions for the European Heart Failure Mission received written responses from the European Commission on the need for specific funding for heart failure care and research.

Raised by Demetris Papadakis MEP and Barry Andrews MEP, the questions highlighted the growing burden that heart failure places on people living with the syndrome and health systems across Europe and called attention to the lack of funding specifically for cardiovascular disease – including heart failure – in large EU funding programmes such as the 2023 EU4Health Work Programme.

Barry Andrews MEP (left) and Demetris Papadakis MEP (right) submitted questions to the European Commission on the lack of specific funding for heart failure in EU funding programmes.

In response to both questions, the European Commissioner for Health and Food Safety, Stella Kyriakides, stated that cardiovascular diseases – and their burden on public health – were covered by the EU’s ‘Healthier Together’ initiative. She reaffirmed the Commission’s ongoing support of Member States in tackling risk factors that contribute to the development of non-communicable diseases.

Heart failure affects 15 million people across Europe, with one in four adults likely to be diagnosed with heart failure during their lifetimes.

The EU must take further action to enshrine future funding for heart failure care and research through programmes such as Horizon Europe and EU4Health to ensure that sustained progress is made in tackling the syndrome. 

Read the response to Demetris Papadakis MEP

Read the response to Barry Andrews MEP

 

Tagged:

More from News & Events

Advancing heart failure care: insights from the Heart Failur
Advancing heart failure care: insights from the Heart Failur...
09 May 2024
The 2024 Heart Failure Policy Summit aimed to share a hopeful outlook on the opportunities that exist to improve heart failure outcomes. So, what did we learn?...
Read article
The Heart Failure Policy Summit returns in April 2024 to bri
The Heart Failure Policy Summit returns in April 2024 to bri...
18 January 2024
This April, the HFPN is delighted to host the Heart Failure Policy Summit 2024....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .